Heather Warkentin

Heather Warkentin

Auto-generated profile, based on publicly available information

Heather Warkentin

Cross Cancer Institute, Edmonton, AB, Canada

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in American Journal of Clinical Oncology
Verified
Journal Article
Closed access
RSRufus Scrimger
Rufus Scrimger
AKAliyah Bsc Kanji
Aliyah Bsc Kanji
MPMatthew Parliament
Matthew Parliament
HWHeather Msc Warkentin
Heather Msc Warkentin
CFColin Msc Field
Colin Msc Field
JHJohn Msc Hanson
John Msc Hanson
Purpose: To investigate the strength of correlation between measured saliva flow rates and various toxicity endpoints commonly used in head and neck cancer (HNC) treatment. Materials and Methods: All patients enrolled in a phase II study using intensity modulated radiotherapy (IMRT) for HNC treatment underwent whole mouth saliva flow measurements (stimulated and unstimulated). They were also assessed for salivary gland toxicity using Radiation Therapy Oncology Group (RTOG) late toxicity grading and 9 items representing patient-graded toxicities from 2 questionnaires (Xerostomia questionnaire and University of Washington quality of life). For each patient, saliva flow rates and quality of life (QOL) data were collected preradiotherapy (RT) and at 3 intervals post-RT (3, 6, and 12 months). Results: A total of 188 sets of coregistered data were obtained for 47 patients over a period of approximately 4 years. Saliva production and mean QOL dropped significantly immediately after RT, but there was a statistically significant recovery in both parameters between 3- and 12-month post-RT. By 12 months, post-RT the mean QOL scores had returned to pre-RT baseline, although mean stimulated saliva production remained 58% below baseline. Conclusion: Patients with HNC treated with IMRT experienced a small drop in QOL which recovered to baseline by 12 months post-RT. There was no statistically significant correlation seen between global health-related QOL scores and stimulated saliva production rates in the post-RT period.

1 May 2011 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
ASAmira Shakam
Amira Shakam
RSRufus Scrimger
Rufus Scrimger
DLDerek Liu
Derek Liu
MMMohamed Mohamed
Mohamed Mohamed
MPMatthew Parliament
Matthew Parliament
SGSunita Ghosh
Sunita Ghosh

1 January 2010 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
KJKurian Joseph
Kurian Joseph
ASAlasdair Syme
Alasdair Syme
CSCormac Small
Cormac Small
HWHeather Warkentin
Heather Warkentin
HQHarvey Quon
Harvey Quon
JPJohn Pedersen
John Pedersen

1 August 2012 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
LCLisa Capelle
Lisa Capelle
HWHeather Warkentin
Heather Warkentin
MMMarc MacKenzie
Marc MacKenzie
KJKurian Joseph
Kurian Joseph
ZGZsolt Gabos
Zsolt Gabos
BABassam Abdulkarim
Bassam Abdulkarim

1 November 2010 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
PDF file
SPS. Patel
S. Patel
HWH. Warkentin
H. Warkentin
KPK. Powell
K. Powell
ASA. Syme
A. Syme
BWB. Warkentin
B. Warkentin
GFG. Fallone
G. Fallone

1 October 2011 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
PDF file
SLS.K. Loewen
S.K. Loewen
KJK. Joseph
K. Joseph
ASA. Syme
A. Syme
HWH. Warkentin
H. Warkentin
CFC. Field
C. Field
TNT. Nijjar
T. Nijjar